688809-99-6 Usage
Description
(R)-2-methoxymethylpiperidine hydrochloride is a chemical compound belonging to the piperidine class of organic compounds. It features a piperidine ring structure with a methoxymethyl group attached at the 2-position and is presented in the form of a hydrochloride salt. (R)-2-methoxymethylpiperidine hydrochloride is recognized for its unique chemical properties and biological activities, which may contribute to the development of new medications and therapeutic agents.
Uses
Used in Pharmaceutical Industry:
(R)-2-methoxymethylpiperidine hydrochloride is used as a building block and intermediate for the synthesis of various drugs. Its unique structure and properties make it a valuable component in the development of new pharmaceutical compounds.
Used in Drug Development:
(R)-2-methoxymethylpiperidine hydrochloride is used as a key component in the development of new medications and therapeutic agents. Its potential applications in this field are attributed to its distinct chemical properties and biological activities, which can be harnessed to create innovative treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 688809-99-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,8,8,0 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 688809-99:
(8*6)+(7*8)+(6*8)+(5*8)+(4*0)+(3*9)+(2*9)+(1*9)=246
246 % 10 = 6
So 688809-99-6 is a valid CAS Registry Number.
688809-99-6Relevant articles and documents
PHARMACEUTICALLY ACTIVE DISUBSTITUTED TRIAZINE DERIVATIVES
-
Page/Page column 53, (2012/09/21)
The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase.
